Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease.
about
Herbal products: benefits, limits, and applications in chronic liver diseaseMethyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels.Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease.Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway.Effects of post-weaning diet on metabolic parameters and DNA methylation status of the cryptic promoter in the A(vy) allele of viable yellow mice.Therapeutic perspectives of epigenetically active nutrients.Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissueNopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats.Plasma choline metabolites associate with metabolic stress among young overweight men in a genotype-specific manner.4-Hydroxynonenal differentially regulates adiponectin gene expression and secretion via activating PPARγ and accelerating ubiquitin-proteasome degradationDietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in MiceMetabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding.Adiponectin in inflammatory and immune-mediated diseasesThe metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathwayEpigenetics in adipose tissue, obesity, weight loss, and diabetes.In ovo injection of betaine alleviates corticosterone-induced fatty liver in chickens through epigenetic modifications.The betaine/GABA transporter and betaine: roles in brain, kidney, and liver.Choline Supplementation Normalizes Fetal Adiposity and Reduces Lipogenic Gene Expression in a Mouse Model of Maternal Obesity.Dietary Betaine Impacts the Physiological Responses to Moderate Heat Conditions in a Dose Dependent Manner in SheepThe Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine.Homocysteine inhibits adipogenesis in 3T3-L1 preadipocytes.Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97Effect of dietary betaine on growth performance, antioxidant capacity and lipid metabolism in blunt snout bream fed a high-fat diet.Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach.Betaine recovers hypothalamic neural injury by inhibiting astrogliosis and inflammation in fructose-fed rats.Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet.Choline and betaine ameliorate liver lipid accumulation induced by vitamin B6 deficiency in rats.FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice.Betaine in Inflammation: Mechanistic Aspects and Applications.Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet.
P2860
Q21284956-E68A610A-A7F9-4CEB-BDCD-2338627E46C2Q33906456-7105D28C-4616-47D8-8A20-60457523F1D7Q34571406-1DF1EE93-A0E7-482D-A46A-4F6FE6C3AD14Q34647400-0EA81460-E070-40F9-9E31-06FFD110DF1EQ34921969-A5D04AF9-56A1-41D1-83DE-6E88E77E5839Q35321755-67E76E1F-6F8C-4172-8328-D79A49A2F577Q35606982-9FD6E000-A0C5-4581-B7D1-C8E7589D3A02Q35631468-ED65CA89-9EBB-4730-AB56-92DF59E96D9EQ35956425-62A1CB5B-3343-41F0-B611-B35B6C0CABEAQ36279928-6E7DD8F5-823F-4C5D-8B26-8F76AFA591E5Q36370586-158B1D4C-88CF-4926-8D8A-C5134FAC908BQ36674013-37F17C2B-F5EE-4350-91D1-A2FD6B540149Q36725805-34084E88-4389-42D5-883B-E92E2F12FEF7Q36759438-F46D2943-6456-4400-9DE1-90FDABC66343Q36922115-ADCC2CB1-D59A-41E1-9974-7AD4DC2D990FQ37164707-5CDF47BB-C553-47BE-925D-76B51C9444F5Q37235361-067DA6E3-BE77-4F47-9153-733F39E5D180Q37446658-1B27DAD7-0CB2-452A-946C-BF3916625901Q37563307-8357D102-EF2E-411A-81F0-199B560674CDQ37735049-C7158AE1-E79A-4B10-B9B8-C1A0136DA381Q38618527-F3DDC682-2998-4934-BD01-584961BD4B93Q39427744-6C4518C8-B149-43DF-B3A1-70BAFACD9E35Q40678269-9400CA00-11EB-45F6-86D5-088C16A06C90Q41463752-3B37A256-77DD-4C6F-A969-B5C5EFD205F4Q42339328-4E75287B-9F42-48BF-9A90-69357FA51EB1Q47161052-23776FF8-59B7-4956-A0A8-5267ACB5393DQ47722592-D5A5285B-74C2-4B84-9A1B-0E7E291DFA47Q47979878-FF263DF2-D8CC-4B1B-A22E-242C3A027D6AQ48490461-7D0FDDE4-1177-4CC3-8AC7-A44ED6272BCBQ49653040-5DD3FFA6-39FE-42C4-876F-BF6BA5EA64D5Q52675518-6E963C79-6387-439E-8E51-EBB7D2960A24Q53467119-0F96A575-F43B-4E23-9A74-18103332565EQ55016760-83A3B3C1-BD6A-4253-9003-E9402312DD24Q55060254-097A6D3E-E518-4EE5-B806-7E702EB71E80
P2860
Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@ast
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@en
type
label
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@ast
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@en
prefLabel
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@ast
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@en
P2093
P2860
P356
P1476
Betaine improved adipose tissu ...... alcoholic fatty liver disease.
@en
P2093
Zhanxiang Zhou
Zhenyuan Song
Zhigang Wang
P2860
P304
P356
10.1152/AJPGI.00249.2009
P577
2010-03-04T00:00:00Z